SPARX3 Study in Parkinson's Disease of Exercise Phase 3 Clinical Trial
What is Sparx 3?
Study in Parkinson Disease of EXercise Phase 3 Clinical TrialHave you been diagnosed with Parkinson’s disease within the past 3 years?
SPARX3 is a research study to learn more about the effects of aerobic exercise on people with Parkinson’s disease who have not yet started medication for their PD. It will compare the effects of moderate intensity treadmill exercise to high intensity treadmill exercise on the signs and symptoms of Parkinson’s disease.
To Take Part in this Research Study
You must:
- Be between 40 to 80 years old
- Have been diagnosed with Parkinson's no more than 3 years ago
- Not currently be taking any PD medications within the next 6 months
- Be able and willing to do moderate to high intensity exercise on a treadmill 4x/week for 18 months and participate in study visits for 24 months
- Be able to travel to the University of Colorado Denver periodically for study related visits
Participants will receive information regarding their health status at no cost.
This may include:
- Physical Examination
- Blood test
- Fitness test
- Exercise Prescription
Contact Us
If you or someone you know would like further information regarding this research study, please contact the study coordinator:
Katherine Balfany
303.724.9101
Principal Investigator:
Cory Christiansen, PT, PhD
This study is funded by The National Institute of Neurological Disorders and Stroke
